Imunon, INC. (IMNN) — 10-Q Filings

All 10-Q filings from Imunon, INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

Imunon Narrows Losses by 29.5%, Cash Dwindles Amid Phase 3 Trial — Nov 13, 2025 Risk: high
Imunon, Inc. (IMNN) reported a net loss of $10.27 million for the nine months ended September 30, 2025, a significant improvement from the $14.56 million net lo
Imunon Posts Continued Losses Amidst Zero Revenue — Aug 5, 2025 Risk: high
Imunon, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its prior year periods. The company posted a net loss of $3.5
Imunon, Inc. Files Q1 2025 10-Q Report — May 12, 2025 Risk: medium
Imunon, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Celsion Corp, is based in Lawrenceville, NJ. Financ
Imunon, Inc. Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
Imunon, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Celsion Corp, is in the pharmaceutical preparations industr
Imunon, Inc. Files Q2 2024 10-Q Report — Aug 14, 2024 Risk: medium
Imunon, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Celsion Corp, is in the pharmaceutical preparations industry. Fi

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX